Literature DB >> 6976987

The purification and properties of human T cell growth factor.

J W Mier, R C Gallo.   

Abstract

Human T cell growth factor (TCGF) has been purified more than 800-fold from serum-free lymphocyte conditioned media by utilizing ion exchange chromatography with DEAE-Sepharose, gel filtration with Ultrogel AcA54, and preparative SDS-polyacrylamide gel electrophoresis. This mitogenic protein, which is released by T cells into the incubating media after exposure to a lectin (PHA), has a m.w. of 13,000 as determined by SDS-PAGE and 20,000 to 25,000 on gel filtration and has an isoelectric point of 6.8. The material extracted from acrylamide gels is a single band (or two nearly superimposed bands) when rerun on analytical SDS gels. Partially purified material is unstable even at -70 degrees C and requires the addition of bovine serum albumin or polyethylene glycol to maintain biologic activity. It is sensitive to proteolytic digestion but resistant to nucleases and thiol-reducing agents such as dithiothreitol. Human TCGF can be reversibly denatured with urea or SDS. Material extracted from acrylamide gels has been shown to sustain T lymphoblasts in tissue culture. In contrast to lectins, certain antigens, and crude lymphocyte conditioned media, purified TCGF does not initiate lymphocyte blastogenesis but is a highly selective mitogen for T cells previously activated by exposure to lectins or antigens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6976987

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Observation of activity of IL-2 produced by mononuclear cells in tumor draining lymph-node.

Authors:  J M Fang; A H Bi
Journal:  J Tongji Med Univ       Date:  1989

2.  Phosphorylation of human interleukin-2 (IL-2).

Authors:  H F Kung; I Calvert; E Bekesi; F R Khan; K P Huang; S Oroszlan; L E Henderson; T D Copeland; R C Sowder; S J Wei
Journal:  Mol Cell Biochem       Date:  1989-08-15       Impact factor: 3.396

3.  The glycoprotein nature and biosynthetic relationship of two molecularly distinct species of primate T-cell growth factor.

Authors:  D S Milstone; C W Parker
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

4.  Interleukin-2 activated peripheral blood lymphocytes and the correlation of lytic activity and peanut agglutinin receptor expression on malignant cells.

Authors:  Y I Gotoh; M Minegishi; Y Yamaguchi; T Konno; K Tada
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  Chromosome 3q (22-ter) encodes the human transferrin receptor.

Authors:  Y E Miller; C Jones; C Scoggin; H Morse; P Seligman
Journal:  Am J Hum Genet       Date:  1983-07       Impact factor: 11.025

6.  Identification and purification of human T-lymphocyte colony-enhancing factor, TLCEF: increased production by phorbol myristate acetate.

Authors:  M M Werber; J Goldman; J Radnay; S Klein; L A Rozenszajn
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

7.  Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells.

Authors:  U Siebenlist; D B Durand; P Bressler; N J Holbrook; C A Norris; M Kamoun; J A Kant; G R Crabtree
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

8.  Mitogen-activated Xenopus laevis lymphocytes produce a T-cell growth factor.

Authors:  D Watkins; N Cohen
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

9.  The role of interleukin-2 in T colony formation by human pre-T cells (pTCFC).

Authors:  A Rey; B Klein; C Ilnicki; M Jourdan; B Serrou
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

10.  Molecular cloning of human interleukin 2 cDNA and its expression in E. coli.

Authors:  R Devos; G Plaetinck; H Cheroutre; G Simons; W Degrave; J Tavernier; E Remaut; W Fiers
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.